CUREVAC NV (CVAC) Stock Fundamental Analysis
USA - NASDAQ:CVAC - NL0015436031 - Common Stock
5.36 USD
-0.02 (-0.37%)
5.36 USD
0 (0%)
Overall CVAC gets a fundamental rating of 6 out of 10. We evaluated CVAC against 534 industry peers in the Biotechnology industry. CVAC is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CVAC has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year CVAC was profitable.
CVAC had a positive operating cash flow in the past year.
CVAC had negative earnings in 4 of the past 5 years.
In multiple years CVAC reported negative operating cash flow during the last 5 years.
1.2 Ratios
CVAC has a Return On Assets of 28.11%. This is amongst the best in the industry. CVAC outperforms 98.13% of its industry peers.
With an excellent Return On Equity value of 33.02%, CVAC belongs to the best of the industry, outperforming 97.75% of the companies in the same industry.
With an excellent Return On Invested Capital value of 28.35%, CVAC belongs to the best of the industry, outperforming 98.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 28.11% | ||
| ROE | 33.02% | ||
| ROIC | 28.35% |
ROA(3y)-13.91%
ROA(5y)-17.17%
ROE(3y)-24.58%
ROE(5y)-30.34%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 37.93%, CVAC belongs to the top of the industry, outperforming 97.57% of the companies in the same industry.
CVAC's Operating Margin of 40.58% is amongst the best of the industry. CVAC outperforms 98.69% of its industry peers.
The Gross Margin of CVAC (94.81%) is better than 94.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 40.58% | ||
| PM (TTM) | 37.93% | ||
| GM | 94.81% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CVAC is creating value.
CVAC has about the same amout of shares outstanding than it did 1 year ago.
CVAC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CVAC has an improved debt to assets ratio.
2.2 Solvency
CVAC has an Altman-Z score of 9.58. This indicates that CVAC is financially healthy and has little risk of bankruptcy at the moment.
CVAC has a Altman-Z score of 9.58. This is amongst the best in the industry. CVAC outperforms 82.40% of its industry peers.
CVAC has a debt to FCF ratio of 0.18. This is a very positive value and a sign of high solvency as it would only need 0.18 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.18, CVAC belongs to the top of the industry, outperforming 96.07% of the companies in the same industry.
CVAC has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
CVAC's Debt to Equity ratio of 0.05 is on the low side compared to the rest of the industry. CVAC is outperformed by 60.86% of its industry peers.
Even though the debt/equity ratio score it not favorable for CVAC, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.18 | ||
| Altman-Z | 9.58 |
ROIC/WACC3.91
WACC7.25%
2.3 Liquidity
CVAC has a Current Ratio of 6.17. This indicates that CVAC is financially healthy and has no problem in meeting its short term obligations.
CVAC has a better Current ratio (6.17) than 64.42% of its industry peers.
A Quick Ratio of 6.16 indicates that CVAC has no problem at all paying its short term obligations.
The Quick ratio of CVAC (6.16) is better than 64.98% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.17 | ||
| Quick Ratio | 6.16 |
3. Growth
3.1 Past
CVAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 170.16%, which is quite impressive.
Looking at the last year, CVAC shows a very strong growth in Revenue. The Revenue has grown by 675.15%.
Measured over the past years, CVAC shows a very strong growth in Revenue. The Revenue has been growing by 98.42% on average per year.
EPS 1Y (TTM)170.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.75%
Revenue 1Y (TTM)675.15%
Revenue growth 3Y73.2%
Revenue growth 5Y98.42%
Sales Q2Q%-91.38%
3.2 Future
Based on estimates for the next years, CVAC will show a very negative growth in Earnings Per Share. The EPS will decrease by -22.50% on average per year.
The Revenue is expected to decrease by -11.22% on average over the next years. This is quite bad
EPS Next Y-170.56%
EPS Next 2Y-63.78%
EPS Next 3Y-28.72%
EPS Next 5Y-22.5%
Revenue Next Year-86.75%
Revenue Next 2Y-59.56%
Revenue Next 3Y-30.85%
Revenue Next 5Y-11.22%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 5.31, which indicates a rather cheap valuation of CVAC.
Compared to the rest of the industry, the Price/Earnings ratio of CVAC indicates a rather cheap valuation: CVAC is cheaper than 98.50% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.76. CVAC is valued rather cheaply when compared to this.
CVAC is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.31 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CVAC indicates a rather cheap valuation: CVAC is cheaper than 99.06% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CVAC is valued cheaper than 99.63% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.29 | ||
| EV/EBITDA | 3.01 |
4.3 Compensation for Growth
The decent profitability rating of CVAC may justify a higher PE ratio.
A cheap valuation may be justified as CVAC's earnings are expected to decrease with -28.72% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-63.78%
EPS Next 3Y-28.72%
5. Dividend
5.1 Amount
No dividends for CVAC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
5.36
-0.02 (-0.37%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners6.53%
Inst Owner Change-0.14%
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap1.21B
Revenue(TTM)510.51M
Net Income(TTM)193.64M
Analysts72.31
Price Target4.92 (-8.21%)
Short Float %0.97%
Short Ratio2.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-29.18%
Min EPS beat(2)-39.67%
Max EPS beat(2)-18.68%
EPS beat(4)2
Avg EPS beat(4)34.62%
Min EPS beat(4)-39.67%
Max EPS beat(4)161.44%
EPS beat(8)3
Avg EPS beat(8)-1.81%
EPS beat(12)5
Avg EPS beat(12)-8.17%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-91.68%
Min Revenue beat(2)-96.47%
Max Revenue beat(2)-86.88%
Revenue beat(4)2
Avg Revenue beat(4)75.38%
Min Revenue beat(4)-96.47%
Max Revenue beat(4)366.65%
Revenue beat(8)4
Avg Revenue beat(8)53.09%
Revenue beat(12)4
Avg Revenue beat(12)21.18%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.9%
EPS NQ rev (1m)-275%
EPS NQ rev (3m)-275%
EPS NY rev (1m)-7.12%
EPS NY rev (3m)-7.12%
Revenue NQ rev (1m)220.62%
Revenue NQ rev (3m)220.62%
Revenue NY rev (1m)-13.81%
Revenue NY rev (3m)-13.75%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 5.31 | ||
| Fwd PE | N/A | ||
| P/S | 2.03 | ||
| P/FCF | 5.29 | ||
| P/OCF | 5.08 | ||
| P/B | 1.77 | ||
| P/tB | 1.85 | ||
| EV/EBITDA | 3.01 |
EPS(TTM)1.01
EY18.84%
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)1.01
FCFY18.91%
OCF(TTM)1.05
OCFY19.68%
SpS2.64
BVpS3.03
TBVpS2.9
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.3
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 28.11% | ||
| ROE | 33.02% | ||
| ROCE | 33.37% | ||
| ROIC | 28.35% | ||
| ROICexc | 78.22% | ||
| ROICexgc | 88.03% | ||
| OM | 40.58% | ||
| PM (TTM) | 37.93% | ||
| GM | 94.81% | ||
| FCFM | 38.42% |
ROA(3y)-13.91%
ROA(5y)-17.17%
ROE(3y)-24.58%
ROE(5y)-30.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover0.74
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.18 | ||
| Debt/EBITDA | 0.14 | ||
| Cap/Depr | 44.58% | ||
| Cap/Sales | 1.55% | ||
| Interest Coverage | 91.31 | ||
| Cash Conversion | 90.71% | ||
| Profit Quality | 101.3% | ||
| Current Ratio | 6.17 | ||
| Quick Ratio | 6.16 | ||
| Altman-Z | 9.58 |
F-Score9
WACC7.25%
ROIC/WACC3.91
Cap/Depr(3y)242.45%
Cap/Depr(5y)397%
Cap/Sales(3y)81.47%
Cap/Sales(5y)93.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)170.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.75%
EPS Next Y-170.56%
EPS Next 2Y-63.78%
EPS Next 3Y-28.72%
EPS Next 5Y-22.5%
Revenue 1Y (TTM)675.15%
Revenue growth 3Y73.2%
Revenue growth 5Y98.42%
Sales Q2Q%-91.38%
Revenue Next Year-86.75%
Revenue Next 2Y-59.56%
Revenue Next 3Y-30.85%
Revenue Next 5Y-11.22%
EBIT growth 1Y171.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-152.22%
EBIT Next 3Y-32.99%
EBIT Next 5Y10.78%
FCF growth 1Y160.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y182.06%
OCF growth 3YN/A
OCF growth 5YN/A
CUREVAC NV / CVAC FAQ
Can you provide the ChartMill fundamental rating for CUREVAC NV?
ChartMill assigns a fundamental rating of 6 / 10 to CVAC.
What is the valuation status of CUREVAC NV (CVAC) stock?
ChartMill assigns a valuation rating of 5 / 10 to CUREVAC NV (CVAC). This can be considered as Fairly Valued.
Can you provide the profitability details for CUREVAC NV?
CUREVAC NV (CVAC) has a profitability rating of 6 / 10.
What are the PE and PB ratios of CUREVAC NV (CVAC) stock?
The Price/Earnings (PE) ratio for CUREVAC NV (CVAC) is 5.31 and the Price/Book (PB) ratio is 1.77.
Can you provide the expected EPS growth for CVAC stock?
The Earnings per Share (EPS) of CUREVAC NV (CVAC) is expected to decline by -170.56% in the next year.